NASDAQ:LUCD
Lucid Diagnostics Inc. Stock News
$0.92
+0.0053 (+0.583%)
At Close: May 22, 2024
PAVmed Provides Business Update and Third Quarter Financial Results
05:43pm, Tuesday, 14'th Nov 2023
Lucid's quarterly revenue increased 392 percent sequentially Veris Health commercial expansion efforts underway, with next-generation Veris Cancer Care Platform launching in Q4 Conference call and web
Lucid Diagnostics Provides Business Update and Third Quarter Financial Results
05:40pm, Monday, 13'th Nov 2023
NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiar
Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor Day
09:00am, Thursday, 09'th Nov 2023
EsoGuard 2.0 incorporates advanced molecular techniques and leverages improvements in sample DNA yields and processes to enhance assay performance and lower costs Lucid Diagnostics Investor Day, where
Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum
09:18am, Thursday, 02'nd Nov 2023
Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-s
Lucid Diagnostics Executes First Direct Employer Contract to Provide EsoGuard® Esophageal Precancer Testing as an Employee Benefit
09:00am, Thursday, 24'th Aug 2023
EsoGuard Testing now incorporated in Texas-based Ancira Auto Group's corporate Health and Wellness Program NEW YORK , Aug. 24, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or
Lucid Diagnostics Inc. (LUCD) Q2 2023 Earnings Call Transcript
12:38pm, Tuesday, 15'th Aug 2023
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q2 2023 Results Conference Call August 15, 2023 8:30 AM ET Company Participants Michael Parks - VP, IR Lishan Aklog - Chairman, CEO Dennis McGrath - EVP, CFO Conf
Lucid Diagnostics Inc. (LUCD) Q1 2023 Earnings Call Transcript
07:39pm, Tuesday, 16'th May 2023
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2023 Results Conference Call May 16, 2023 8:30 AM ET Company Participants Michael Parks - VP, IR Dr. Lishan Aklog - Chairman and CEO Dennis McGrath - CFO Confe
Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference
09:45pm, Monday, 17'th Apr 2023
NEW YORK, April 17, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiar
Lucid to cut 1,300 workers amid signs of flagging demand for its EVs
04:41pm, Tuesday, 28'th Mar 2023
Lucid CEO Peter Rawlinson said the job cuts will hit "nearly every organization and level, including executives."
Lucid Diagnostics Inc. (LUCD) Q4 2022 Earnings Call Transcript
02:18pm, Tuesday, 14'th Mar 2023
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q4 2022 Earnings Conference Call March 14, 2023 8:30 AM ET Company Participants Michael Parks - Vice President, Investor Relations Dr. Lishan Aklog - Chairman and
Lucid Diagnostics Inc. (LUCD) Q3 2022 Earnings Call Transcript
09:50pm, Monday, 14'th Nov 2022
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Adrian Miller - Vice President-Investor Relations Lishan Aklog - Chairman & Chi
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 14, 2022
08:25am, Wednesday, 02'nd Nov 2022
NEW YORK--(BUSINESS WIRE)-- #CheckYourFoodTube--Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, a majority-owned subsidiary of PA
Lucid Diagnostics Inc. (LUCD) CEO Lishan Aklog on Q2 2022 Results - Earnings Call Transcript
09:57pm, Monday, 15'th Aug 2022
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Adrian Miller - Vice President-Investor Relations Lishan Aklog - Chairman & Chief
Lucid Diagnostics to Hold a Business Update Conference Call on August 15, 2022
08:25am, Monday, 01'st Aug 2022
NEW YORK--(BUSINESS WIRE)---- $LUCD #businessupdate--Lucid Diagnostics Inc. announced that the Company will host a business update conference call on Monday, August 15, 2022, at 4:30 PM EDT.
Lucid Diagnostics' (LUCD) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript
09:18pm, Wednesday, 11'th May 2022
Lucid Diagnostics Inc. (NASDAQ:LUCD ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Adrian Miller – Vice President-Investor Relations Lishan Aklog – Chairman and Ch
